PVP Ventures
NSE
₹ 0.00
0.00 (0.00)%
Small-cap
With a market cap of ₹18.90L Cr.
EX-Date | Purpose |
---|---|
22 06 2021 | Audited Results |
11 08 2021 | Quarterly Results |
11 11 2021 | Quarterly Results |
11 02 2022 | Quarterly Results |
25 05 2022 | Audited Results |
04 07 2022 | Inter alia, to consider and approve Intimation under Regulation 50(1), 52(1) and 57(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 |
12 08 2022 | Quarterly Results |
11 11 2022 | Quarterly Results |
13 02 2023 | Quarterly Results |
28 04 2023 | Preferential Issue of shares |
28 04 2023 | Inter-alia to consider and approve conversion of 5,000 14.5% Fully Convertible Debentures into Equity Shares of the Company. |
28 04 2023 | Preferential Issue of shares & Inter-alia, to consider the issue of equity shares of the company by way of preferential issue for the purpose of acquisition of a company engaged in healthcare business for consideration other than cash, for which issuance and allotment of equity shares shall be in accordance with applicable laws and shall be subject to such regulatory approvals, as may be required, including shareholders? approval. |
16 05 2023 | Preferential Issue of shares & Employees Stock Option Plan |
16 05 2023 | Employees Stock Option Plan(Cancelled) (Cancelled)& Preferential Issue of shares(Cancelled) |
23 05 2023 | Audited Results |
22 06 2023 | Preferential Issue of shares(Cancelled) (Cancelled) |
02 08 2023 | Quarterly Results |
24 08 2023 | Preferential Issue of shares |
08 11 2023 | Quarterly Results |
12 02 2024 | Quarterly Results |
13 02 2024 | Quarterly Results (Revised) |
12 11 2024 | Quarterly Results |
07 02 2025 | Inter alia, to consider and discuss the following business: the proposal for raising of funds by way of issuance of Non-Convertible Debentures by way of Private Placement in terms of Securities & Exchange Board of India (Issue and Listing of Non-Convertible Securities) Regulations, 2021 and all the incidental activities for the proposed issue. |
14 02 2025 | Quarterly Results |
31 03 2025 | Inter alia, to consider and approve the amendment of Articles of Association of the Company and all the incidental activities for the proposed amendment. |
No News data available